Annie Mitsak
InvestorPartner at Cure Ventures Β· Principal at Omega Funds Β· Board director at Alessa Therapeutics
Boston, Massachusetts, United States
About
Partner with over ten years in academic licensing and venture investing. Previously spent over six years on the Omega Funds investment team and worked at MIT's Technology Licensing Office.
ContactΒ· published on Annie's own website
Board director at Alessa Therapeutics
Intro paths
β
In turn, Annie can intro founders to Alessa Therapeutics's investors below.
Alessa Therapeutics's investors Β· 4
Co-founders at Alessa Therapeutics
PM

Pamela MunsterFounder, Chief Scientific Advisor and Director
Experience
- Triton Therapeutics, Inc.Board Membercurrent2025 β present
- Alessa Therapeutics, Inc.Board Membercurrent2025 β present
- Cure VenturesPartnercurrent2023 β presentBoston, Massachusetts, United States
- Photys TherapeuticsBoard Observer2021 β 2022
- Rectify PharmaBoard Observer2021 β 2022
- Scorpion TherapeuticsBoard Observer2021 β 2022
- Anjarium BiosciencesBoard Observer2021 β 2022
- Omega FundsPrincipal2019 β 2022
- Omega FundsAssociate2015 β 2019Boston, MA
- Ikena OncologyBoard Observer2020 β 2021
- Checkmate PharmaceuticalsBoard Observer2020
- Trevi Therapeutics, Inc.Member Board Of Directors2018 β 2020
- Massachusetts Institute of Technology (MIT)Associate Technology Licensing Officer2014 β 2015
- Massachusetts Institute of Technology (MIT)Technology Licensing Associate2012 β 2014Cambridge, MA
- Nelsen BiomedicalIndependent Consultant2015
- University of MichiganPostdoctoral fellow2012Ann Arbor, MI
- Kaplan Test Prep and AdmissionsGRE Instructor2007
- Penn State UniversityResearch Assistant2005
- Johns Hopkins UniversityResearch Assistant2004Baltimore, MD
Skills & more
Contract NegotiationDrafting AgreementsPeer MentoringPatent Portfolio AnalysisBiomedical EngineeringLicensing
From Annie's professional profile.
Investments
Board seats
Per SEC Form D filings.
Colleagues at Cure Ventures
Albert J. Robichaud
Partner at Cure Ventures
Bill Amsbaugh
CTO and Partner at Cure Ventures
Courtney Turner
Director of Finance at Cure Ventures
David Fallace
Managing Partner at Cure Ventures
Dr. Michael Aberman
Investor at Cure Ventures
Dr. Milenko Cicmil
Investor at Cure Ventures
Drew King
CFO and Partner at Cure Ventures
Jeffrey M. Jonas
Partner at Cure Ventures
Network6
Alex Delbridge
Senior Associate at Omega Funds
Bernard Davitian
Partner at Omega Funds
Francesco Draetta
Managing Director at Omega Funds
Katie Kerfoot
Vice President at Omega Funds
Michael Powell
Partner at Omega Funds
Thomas Goebel
Principal at Omega Funds
Investors connected to Annie in public investor directories β a warm-intro map.
Frequently asked questions
- Who is Annie Mitsak?
- Partner with over ten years in academic licensing and venture investing. Previously spent over six years on the Omega Funds investment team and worked at MIT's Technology Licensing Office.
- Where does Annie Mitsak work?
- Annie Mitsak is Partner at Cure Ventures and Board director at Alessa Therapeutics.
- What boards does Annie Mitsak sit on?
- Annie Mitsak holds tracked board seats at Alessa Therapeutics, Triton Therapeutics, Inc..
- Where did Annie Mitsak go to school?
- Annie Mitsak studied at University of Michigan (PhD, Biomedical Engineering); University of Michigan (M.S., Biomedical Engineering); University of Virginia (BS, Biomedical Engineering).
Same school
Also attended University of Michigan667
Erik TorenbergGeneral Partner at Andreessen Horowitz; founder of TurpentineKarim FarisInvestor at GV (Google Ventures)Glen AndersonPartner at Monta Vista CapitalAlexandra FarmerPrincipal at Intel Capital, North AmericaScott ShawChief of Staff at Intel CapitalZach PoleyPartner and Chief Technology Officer at Clear Ventures
+ 661 more
Also attended University of Virginia576
Alexis OhanianFounder & General Partner of Seven Seven SixAndy FligelSenior Managing Director at Intel CapitalKandace ElamVice President of GTM Talent at Menlo VenturesTrevor KienzleInvestor at Correlation VenturesLauren von ReynInvestor at LightbankFrank RotmanCo-Founder and Partner Emeritus at QED Investors
+ 570 more
Shared employers
Also worked at Alessa Therapeutics, Inc.1
Also worked at Anjarium Biosciences2
Also worked at Omega Funds19
Nessan BerminghamInvestor at Khosla VenturesLiam FlahertyInvestor at Silversmith Capital PartnersRichard LimManaging Partner at Cure VenturesJohn MaraganoreAdvisor at Oak HC/FTWalter StockingerManaging Partner at Hadean VenturesKeno GutierrezGeneral Partner at BioGeneration Ventures
+ 13 more
Also worked at Massachusetts Institute of Technology (MIT)602
Aileen LeeFounder & Managing Partner of Cowboy VenturesMatt HuangCo-founder and Managing Partner at ParadigmMichael TruellCo-founder & CEO of CursorRaquel UrtasunFounder & CEO of WaabiColin WebbFounder & CEO of Avatar RoboticsAbraham BachrachCo-founder & CTO of Skydio
+ 596 more









































